IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Iridex Corp

IRIDEX Corporation designs and manufactures ophthalmic medical devices, including lasers and surgical instruments for the treatment of eye diseases. The company self-describes its technology as patented and specialized in laser solutions for glaucoma and retinal conditions.

COM:IRIDEX

IRIDEX Corporation

Last Close

1.73

22/11 21:00

Market Cap

29.95M

Beta: -

Volume Today

26.70K

Avg: -

Financials Not Available